Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous Thrombosis
Clinical trial NCT07523347 · COMPLETED
Trial details
- NCT number
- NCT07523347
- Sponsor
- Muhammad Aamir Latif
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2025-12-31
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.